Policies put in place during the pandemic prevent many small banks and credit unions from selling small-balance loans to the GSEs, which constrains mortgage lending in rural and low-income communities.

The Second Circuit Court of Appeals altered some of its original findings in a lawsuit dealing with MBS liability under the Employee Retirement Income Security Act.

Issuance of expanded-credit MBS increased a hefty 40.6% during the first quarter of 2026, with investment-property mortgages making up a big chunk of the total. (Includes three data tables.)

The comment period on a concept release from the SEC to revise disclosure requirements on MBS and ABS closed in December. Since then, SEC officials have held a number of meetings with industry groups.

The rapid rise in investor interest for home equity loan securitizations has drawn parallels to the rise of non-QM MBS post the 2008 crisis.

Liability under ERISA for MBS structures could be impacted by a recent appeals court’s ruling in a long-running lawsuit.

The revised proposals would reduce capital requirements for banks, both for MBS holdings and whole loans in portfolio. The change would provide incentives for banks to retain more originations in portfolio.

Some 68.0% of mortgages originated in 2025 were sold into MBS. Securitization rates were stable across most products, except for expanded-credit mortgages, where the securitization rate increased sharply. (Includes data table.)

Morningstar DBRS has proposed loosening its rating criteria for residential MBS, given the strong performance of loans originated after 2008.

Mortgages for medical doctors are usually retained in bank portfolios.